NPI: 1437592292 · DINUBA, CA 93618 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/11/2013
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/11/2013 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 13,728 | $889K |
| 2019 | 15,491 | $540K |
| 2020 | 8,391 | $557K |
| 2021 | 6,615 | $821K |
| 2022 | 8,665 | $1.04M |
| 2023 | 17,009 | $1.52M |
| 2024 | 12,680 | $1.14M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 52,991 | 4,220 | $6.34M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 10,941 | 669 | $84K |
| A4657 | Syringe, with or without needle, each | 5,722 | 1,635 | $59K |
| J1270 | Injection, doxercalciferol, 1 mcg | 2,836 | 207 | $9K |
| J1756 | Injection, iron sucrose, 1 mg | 3,519 | 1,057 | $5K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,021 | 682 | $4K |
| 90677 | 34 | 34 | $1K | |
| 83970 | 447 | 440 | $825.62 | |
| 0002A | 13 | 13 | $750.00 | |
| 0250 | 2,844 | 243 | $628.16 | |
| G0008 | Administration of influenza virus vaccine | 192 | 181 | $255.25 |
| 90674 | 143 | 125 | $155.14 | |
| G0009 | Administration of pneumococcal vaccine | 32 | 32 | $137.49 |
| 90662 | 22 | 22 | $100.07 | |
| 82728 | 290 | 263 | $53.48 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 35 | 35 | $45.68 |
| 90661 | 18 | 18 | $34.86 | |
| 83540 | 281 | 252 | $25.40 | |
| 85041 | 512 | 457 | $17.06 | |
| 85048 | 434 | 421 | $14.44 | |
| 83550 | 191 | 164 | $5.34 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 31 | 26 | $0.00 |
| 82607 | 15 | 15 | $0.00 | |
| 82108 | 15 | 15 | $0.00 |